NCT04265573View on ClinicalTrials.gov

Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies

CompletedOBSERVATIONAL

Enrollment

150,000

Participants

Timeline

Start Date

November 10, 2018

Primary Completion Date

December 1, 2020

Study Completion Date

February 25, 2021

Conditions

Malaria

Trial Locations (1)

Unknown

Groupe de Recherche Action en Santé, Ouagadougou

All Listed Sponsors

collaborator

Medicines for Malaria Venture

OTHER

collaborator

National Malaria Control Programme (NMCP), Burkina Faso

UNKNOWN

collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

lead

Groupe de Recherche Action en Sante

OTHER

NCT04265573 - Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies | Biotech Hunter | Biotech Hunter